China's Biotech Revolution

This chapter explores China's rapid advancements in the biotechnology and pharmaceutical industries, transitioning from generic drug production to innovative treatment development. It examines the global implications of these advancements, particularly the competition between Chinese and Western firms, and how these changes affect drug licensing and market dynamics. Additionally, the chapter discusses the impact of geopolitical factors and the potential benefits of Chinese-originated drugs entering the Western market.